米国の抗アンドロゲン市場

QYResearchが出版した調査資料(QYR70416014)・商品コード:QYR70416014
・発行会社(調査会社):QYResearch
・発行日:2017年3月3日
・ページ数:102
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:米国
・産業分野:医療・製薬・バイオ
◆販売価格オプション(消費税別)
Single UserUSD3,800 ⇒換算¥414,200見積依頼/購入/質問フォーム
EnterpriseUSD7,600 ⇒換算¥828,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、米国の抗アンドロゲン市場について調査・分析し、抗アンドロゲンの米国市場概観、抗アンドロゲンの種類別市場分析、用途別市場分析、抗アンドロゲンの米国市場規模予測、関連企業分析、関連企業情報、価格情報、販売動向、米国市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・抗アンドロゲンの米国市場概観
・抗アンドロゲンの種類別市場規模
・抗アンドロゲンの用途別市場規模
・抗アンドロゲンの米国市場規模
・抗アンドロゲンの米国市場予測
・抗アンドロゲンの製造メーカー分析
・抗アンドロゲンのメーカー別生産量
・抗アンドロゲンのメーカー別市場シェア
・抗アンドロゲンの価格動向・価格分析
・抗アンドロゲンの販売(売上高)動向
・抗アンドロゲンの貿易(輸出・輸入)動向
・抗アンドロゲンの産業チェーン分析
・抗アンドロゲンのマーケティング戦略分析
・抗アンドロゲンの販売業者(代理店)リスト
・抗アンドロゲンの市場環境分析
...
【レポートの概要】

Notes:Sales, means the sales volume of Antiandrogen
Revenue, means the sales value of Antiandrogen

This report studies sales (consumption) of Antiandrogen in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Pfizer
Abbott Laboratories
Genentech
GlaxoSmithKline
Immunomedics
Indevus Pharmaceuticals
Novartis AG

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Antiandrogen in each application, can be divided into
Application 1
Application 2

【レポートの目次】

Table of Contents

United States Antiandrogen Market Report 2017
1 Antiandrogen Overview
1.1 Product Overview and Scope of Antiandrogen
1.2 Classification of Antiandrogen
1.2.1 Type I
1.2.2 Type II
1.3 Application of Antiandrogen
1.3.1 Application 1
1.3.2 Application 2
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Antiandrogen (2012-2022)
1.4.1 United States Antiandrogen Sales and Growth Rate (2012-2022)
1.4.2 United States Antiandrogen Revenue and Growth Rate (2012-2022)

2 United States Antiandrogen Competition by Manufacturers
2.1 United States Antiandrogen Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Antiandrogen Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Antiandrogen Average Price by Manufactures (2015 and 2016)
2.4 Antiandrogen Market Competitive Situation and Trends
2.4.1 Antiandrogen Market Concentration Rate
2.4.2 Antiandrogen Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Antiandrogen Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Antiandrogen Sales and Market Share by States (2012-2017)
3.2 United States Antiandrogen Revenue and Market Share by States (2012-2017)
3.3 United States Antiandrogen Price by States (2012-2017)

4 United States Antiandrogen Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Antiandrogen Sales and Market Share by Type (2012-2017)
4.2 United States Antiandrogen Revenue and Market Share by Type (2012-2017)
4.3 United States Antiandrogen Price by Type (2012-2017)
4.4 United States Antiandrogen Sales Growth Rate by Type (2012-2017)

5 United States Antiandrogen Sales (Volume) by Application (2012-2017)
5.1 United States Antiandrogen Sales and Market Share by Application (2012-2017)
5.2 United States Antiandrogen Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Antiandrogen Manufacturers Profiles/Analysis
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Antiandrogen Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Abbott Laboratories
6.2.2 Antiandrogen Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Abbott Laboratories Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Genentech
6.3.2 Antiandrogen Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Genentech Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline
6.4.2 Antiandrogen Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 GlaxoSmithKline Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Immunomedics
6.5.2 Antiandrogen Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Immunomedics Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Indevus Pharmaceuticals
6.6.2 Antiandrogen Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Indevus Pharmaceuticals Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Novartis AG
6.7.2 Antiandrogen Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Novartis AG Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview

7 Antiandrogen Manufacturing Cost Analysis
7.1 Antiandrogen Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antiandrogen

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Antiandrogen Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antiandrogen Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Antiandrogen Market Forecast (2017-2022)
11.1 United States Antiandrogen Sales, Revenue Forecast (2017-2022)
11.2 United States Antiandrogen Sales Forecast by Type (2017-2022)
11.3 United States Antiandrogen Sales Forecast by Application (2017-2022)
11.4 Antiandrogen Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Antiandrogen
Table Classification of Antiandrogen
Figure United States Sales Market Share of Antiandrogen by Type in 2015
Table Application of Antiandrogen
Figure United States Sales Market Share of Antiandrogen by Application in 2015
Figure United States Antiandrogen Sales and Growth Rate (2012-2022)
Figure United States Antiandrogen Revenue and Growth Rate (2012-2022)
Table United States Antiandrogen Sales of Key Manufacturers (2015 and 2016)
Table United States Antiandrogen Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Antiandrogen Sales Share by Manufacturers
Figure 2016 Antiandrogen Sales Share by Manufacturers
Table United States Antiandrogen Revenue by Manufacturers (2015 and 2016)
Table United States Antiandrogen Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Antiandrogen Revenue Share by Manufacturers
Table 2016 United States Antiandrogen Revenue Share by Manufacturers
Table United States Market Antiandrogen Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Antiandrogen Average Price of Key Manufacturers in 2015
Figure Antiandrogen Market Share of Top 3 Manufacturers
Figure Antiandrogen Market Share of Top 5 Manufacturers
Table United States Antiandrogen Sales by States (2012-2017)
Table United States Antiandrogen Sales Share by States (2012-2017)
Figure United States Antiandrogen Sales Market Share by States in 2015
Table United States Antiandrogen Revenue and Market Share by States (2012-2017)
Table United States Antiandrogen Revenue Share by States (2012-2017)
Figure Revenue Market Share of Antiandrogen by States (2012-2017)
Table United States Antiandrogen Price by States (2012-2017)
Table United States Antiandrogen Sales by Type (2012-2017)
Table United States Antiandrogen Sales Share by Type (2012-2017)
Figure United States Antiandrogen Sales Market Share by Type in 2015
Table United States Antiandrogen Revenue and Market Share by Type (2012-2017)
Table United States Antiandrogen Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antiandrogen by Type (2012-2017)
Table United States Antiandrogen Price by Type (2012-2017)
Figure United States Antiandrogen Sales Growth Rate by Type (2012-2017)
Table United States Antiandrogen Sales by Application (2012-2017)
Table United States Antiandrogen Sales Market Share by Application (2012-2017)
Figure United States Antiandrogen Sales Market Share by Application in 2015
Table United States Antiandrogen Sales Growth Rate by Application (2012-2017)
Figure United States Antiandrogen Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Antiandrogen Sales Market Share (2012-2017)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Laboratories Antiandrogen Sales Market Share (2012-2017)
Table Genentech Basic Information List
Table Genentech Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
Table Genentech Antiandrogen Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Antiandrogen Sales Market Share (2012-2017)
Table Immunomedics Basic Information List
Table Immunomedics Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
Table Immunomedics Antiandrogen Sales Market Share (2012-2017)
Table Indevus Pharmaceuticals Basic Information List
Table Indevus Pharmaceuticals Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
Table Indevus Pharmaceuticals Antiandrogen Sales Market Share (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Antiandrogen Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis AG Antiandrogen Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antiandrogen
Figure Manufacturing Process Analysis of Antiandrogen
Figure Antiandrogen Industrial Chain Analysis
Table Raw Materials Sources of Antiandrogen Major Manufacturers in 2015
Table Major Buyers of Antiandrogen
Table Distributors/Traders List
Figure United States Antiandrogen Production and Growth Rate Forecast (2017-2022)
Figure United States Antiandrogen Revenue and Growth Rate Forecast (2017-2022)
Table United States Antiandrogen Production Forecast by Type (2017-2022)
Table United States Antiandrogen Consumption Forecast by Application (2017-2022)
Table United States Antiandrogen Sales Forecast by States (2017-2022)
Table United States Antiandrogen Sales Share Forecast by States (2017-2022)



★調査レポート[米国の抗アンドロゲン市場] (コード:QYR70416014)販売に関する免責事項を必ずご確認ください。
★調査レポート[米国の抗アンドロゲン市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆